Printer Friendly Version

Section: Diagnostic Medical
Number: M-13
Topic: Neurophysiological Studies
Effective Date: November 3, 2008
Issued Date: November 3, 2008
Date Last Reviewed: 08/2008

General Policy Guidelines

Indications and Limitations of Coverage

Neurophysiological studies may be reimbursed individually whether performed independently or in conjunction with each other.

However, if a provider reports any neurophysiological studies (92586, 92589, 95812, 95813, 95816, 95819, 95822, 95827, 95925, 95926, 95927, 95928, 95929, 95930, 95950, 95951, 95954, 95956) in addition to comprehensive evoked response audiometry (92585), the charges should be combined and processed under code 92585 (e.g., 92585 + 92589 = 92585).  Modifier 59 may be reported with a non-E/M service, to identify it as distinct or independent from other non-E/M services performed on the same day.  When modifier 59 is reported, the patient’s records must support its use in accordance with CPT guidelines.

Magnetoencephalography and Magnetic Source Imaging
Magnetoencephalography (MEG) (95965, 95966, 95967) and Magnetic Source Imaging (MSI) (S8035) are eligible for use in the presurgical evaluation of certain patients with medically refractory epilepsy.*  This includes:

  • non-lesional superficial cortical epilepsy
  • lesional epilepsy within or adjacent to the eloquent cortex, 
  • epilepsy associated with large structural lesions, 
  • ongoing or recurrent seizure activity following previous resections for epilepsy, and
  • cases where the seizure focus has not been detected or well localized by traditional methods.

*Medically refractory epilepsy refers to the failure of adequate trials of different classes of FDA approved antiepilepsy medications to control seizure activity, when taken in appropriate doses and carefully monitored for effectiveness and patient compliance.

MEG/MSI is also considered eligible for use in presurgical functional brain mapping (PSFBM) for the preoperative evaluation of intracranial lesions located near the eloquent cortex or essential functional areas of the brain.

Other uses of MEG/MSI are considered experimental/investigational, and are not covered.  A participating, preferred, or network provider can bill the member for the denied service.

Intraoperative Neurophysiology Monitoring
Intraoperative neurophysiology monitoring should be reported under procedure code 95920, regardless of the specific monitoring performed (e.g., brainstem auditory evoked response, somatosensory evoked potentials, etc.) If any of the testing codes for neurophysiological monitoring which are addressed below in the "Description" area of this policy are reported in conjunction with 95920, the services should be combined and processed under 95920 (e.g., 95925 + 95920 = 95920).  Modifier 59 may be reported with a non-E/M service, to identify it as distinct or independent from other non-E/M services performed on the same day.  When modifier 59 is reported, the patient’s records must support its use in accordance with CPT guidelines.

Intraoperative neurophysiology monitoring is an eligible service when it is performed by an eligible professional provider for any of the following indications:

  • Acoustic neuroma
  • Anterior cervical corpectomy
  • Carotid endarterectomy
  • Cerebral vascular aneurysms
  • Cervical or thoracic myelopathy
  • Dorsal rhizotomy
  • Exploration of peripheral nerve neuroma
  • Fracture of the spine
  • Hemifacial spasm, 7th nerve decompression operation
  • Herniated nucleus pulposus with spinal cord compression and wedge graft surgery following anterior cervical discectomy
  • Leg lengthening procedure
  • Most spinal instrumentation procedures
  • Scoliosis
  • Spinal arteriovenous malformation
  • Spinal cord trauma
  • Spinal stenosis
  • Spondylolisthesis
  • Spondylosis
  • Syringomyelia
  • Tethered cord
  • Thoracic disc disease
  • Trigeminal neuralgia, 5th nerve decompression operation
  • Tumor of the CNS or peripheral NS
  • Unstable spine

Individual consideration may be given for indications other than those above.  The physician must be performing the service in real time.  The physician may be in the O.R. suite or at a remote site with the monitoring performed via digital transmission or closed circuit television.  When digital transmission or closed circuit television is used, there must be the ability for continuous or immediate contact with the operating surgeon to ensure that information about the patient's status can be immediately communicated.

Description

Neurophysiological studies is a generic term for objective tests performed via sophisticated electronic equipment to detect various neurological dysfunctions. They include the following studies:

  • Electroencephalography (EEG) - 95812-95813, 95816-95822, 95827, 95950, 95951, 95954, 95956
  • Evoked response audiometry (ERA) - 92585, 92586
  • Visual evoked potential (VEP) - 95930
  • Central auditory testing - 92589
  • Somatosensory evoked potential (SEP) testing -95925, 95926, 95927
  • Central motor evoked potential study (transcranial motor stimulation) - 95928, 95929 

(The above codes represent testing performed in a nonoperative setting.)

NOTE: Evoked response audiometry (92585, 92586) can also be reported as:

  • Brain stem auditory evoked response (BAER)
  • Electrophysiological response audiometry
  • Electrical response audiometry
  • Evoked potential audiometry
  • Low or high level biophysical EEG

Magnetoencephalography
Magnetoencephalography (MEG) measures neurological activity of the brain using magnetic fields. It is used for fundamental study of the brain, and for clinical studies and assessment of patients with specific neurological disorders. MEG is a noninvasive functional imaging technique in which the weak magnetic forces associated with the electrical activity of the brain are recorded externally on the scalp. Using mathematical modeling, the recorded data are then analyzed to provide an estimated location of the electrical activity. This information can be superimposed on an anatomic image of the brain, typically an MRI, to produce a functional/anatomic image of the brain, referred to as magnetic source imaging (MSI)

MEG and MSI have been found to be useful in the anatomical localization of areas of seizure focus and epileptogenic lesions of the brain, and in predicting outcomes in surgical resections for intractable temporal lobe epilepsy and brain lesions.

The primary advantage of MSI is that while the conductivity and thus measurement of electrical activity as recorded by the EEG is altered by surrounding brain structures, the magnetic fields are not. Therefore, MSI permits a high resolution functional/anatomic image.  This allows precise localization of epileptiform activity and anatomical identification of brain lesions.  Use of MEG/MSI in presurgical functional brain mapping (PSFBM) helps to determine whether surgical resection of a brain lesion is feasible, and improves the safety and accuracy of tumor resection while reducing the risk of postoperative functional deficits.

Intraoperative Neurophysiology Monitoring
Intraoperative neurophysiology monitoring is used to identify complications to the nervous system during certain surgical procedures. Evoked responses are constantly monitored for changes which could imply damage to the nervous system. The intent of this monitoring is to alert the surgeon so that he may possibly alter the surgical procedure to avoid permanent neurological damage.


NOTE:
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.

Procedure Codes

925859258692589958129581395816
958199582295827959209592595926
959279592895929959309595095951
9595495956959659596695967S8035

Traditional (UCR/Fee Schedule) Guidelines

Refer to General Policy Guidelines

FEP Guidelines

This medical policy may not apply to FEP.  Medical policy is not an authorization, certification, explanation of benefits or a contract.  Benefits are determined by the Federal Employee Program.

Comprehensive / Wraparound / PPO / Major Medical Guidelines

Refer to General Policy Guidelines

Any reference in this bulletin to non-billable services by a network provider may not be applicable to Major Medical.

Managed Care (HMO/POS) Guidelines

Refer to General Policy Guidelines

Publications

PRN References

03/1994, Intraoperative neurophysiology testing, coding for
03/1995, Intraoperative neurophysiology monitoring, codes and reimbursement for
06/2005, Blue Shield covers real time on-site and remote-location intraoperative neurophysiological monitoring
08/2007, Magnetoencephalography (MEG) and Magnetic Source Imaging (MSI) now eligible
12/2008, MEG/MSI eligible for presurgical functional brain mapping (PSFBM)

References

Epilepsy Surgery, Resection Volume and MSI Localization in Lesional Frontal Lobe Epilepsy, Elsevier Ireland, Ltd., 08/2003

Magnetoencephalography (MEG) Predicts Focal Epileptogenicity in Cavarnomas, The Journal of Neurology, Neurosurgery and Psychiatry, 2004

Does Magnetoencephalography Add to Scalp Video-EEG as a Diagnostic Tool in Epilepsy Surgery? Neurology, Volume 62, 03/2004

Magnetoencephalography Source Localization and Surgical Outcome in Temporal Lobe Epilepsy, Elsevier Ireland, Ltd, 06/2004

Application of Magnetoencephalography in Epilepsy Patients with Widespread Spike or Slow-wave Activity, Epilepsia, Volume 46, Number 8, 2005

Detection of Epileptiform Activity by Human Interpreters: Blinded Comparison Between Electroencephalography and Magnetoencephalography, Epilepsia, Volume 46, Number 1, 2005

Dynamic Statistical Parametric Mapping for Analyzing the Magnetoencephalographic Epileptiform Activity in Patients with Epilepsy, Journal of Child Neurology, Volume 20, 04/2005

Toward the Substitution of Invasive Electroencephalography in Epilepsy Surgery, The Journal of Clinical Neurophysiology, Volume 22, Number 4, 08/2005

Magnetic Source Imaging Localizes Epileptogenic Zone in Children with Tuberous Sclerosis Complex, Neurology, Volume 66, 04/2006

Reliability of Language Mapping with Magnetic Source Imaging in Epilepsy Surgery Candidates, Elsevier Ireland, Ltd, 04/2006

Magnetoencephalography/Magnetic Source Imaging, MPRM, Policy 6.01.21, 12/12/2006

Kakigi R, Hoshiyama M, Shimojo M, Naka D, Yamasaki H, Watanabe S, Xiang J, Maeda K, Lam K, Itomi K, Nakamura A. The somatosensory evoked magnetic fields. Progress in Neurobiology. 1999:61:495-523. 

Albertstone CD, Skirboll SL, Benzel EC, Sanders JA, Hart BL, Baldwin NG, Tessman CL, Davis JT, Lee RR. Magnetic source imaging and brain surgery: presurgical and intraoperative planning in 26 patients. Journal of Neurosurgery. 2000;92:79-90. 

Oishi M, Fukuda M, Kameyama S, Kawaguchi T, Masuda H, Tanaka R. Magnetoencephalographic representation of the sensorimotor hand area in cases of intracerebral tumor. Journal of Neurology, Neurosurgery, and Psychiatry. 2003;74:1649-1654. 

Papanicolaou AC, Simos PG, Castillo EM, Billingsley RL, Buchanan S, Wheless J, Maggio V, Maggio WW.  Magnetoencephalography: a noninvasive alternative to the wada procedure. Journal of Neurosurgery. 2004;100:867-76. 

Ganslandt O, Buchfelder M, Hastreiter P, Grummich P, Fahlbusch R, Nimsky C. Magnetic source imaging supports clinical decision making in glioma patients. Clinical Neurology and Neurosurgery. 2004;107:20-26.

Grover KM, Bowyer SM, Rock ML, Rosenblum KM, Moran JE, Smith BJ, Barkley GL. Retrospective review of MEG visual evoked hemifield responses prior to resection of temporo-parieto-occipital lesions. Journal of Neuro-Oncology. 2005.

Makela J, Forss N, Jaaskelainen J, Kirveskari E, Korvenoja A, Paetau R. Magnetoencephalography in neurosurgery. Neurosurgery. 2006;59:493-511. 

Grummich P, Nimsky C, Pauli E, Buchfelder M, Ganslandt O. Combining fMRI and MEG increases the reliability of pre-surgical language localization: a clinical study of the difference between and congruence of both modalities. Neuroimage. 2006;32:1793-1803.

Korvenoja A, Kirveskari, Aronen HJ, Avikainen S, Brander A Huttunen J, Ilmoniemi RJ, Jaaskelainen JE, Kovala T, Makela JP, Salli E, Seppa M. Sensorimotor cortex localization: comparison of magnetoencephalography, functional MR imaging, and intraoperative cortical mapping. Radiology. 2006;241:213-22.

Kamada K, Sawamura Y, Takeuchi F, Kuriki S, Kawai K, Morita A, Todo T. Expressive and receptive language areas determined by a non-invasive reliable method using functional magnetic resonance imaging and magnetoencephalography. www.neurosurgery-online.com. 2007;60:296-306.

Larsen S, Kikinis R, Talos IF, Weinstein D, Wells W, Golby A. Quantitative comparison of functional MRI and direct electrocortical stimulation for functional mapping. International Journal of Medical Robotics and Computer-Assisted Surgery. 2007;3:262-70.

Stippich C, Rapps N, Dreyhaupt J, Durst A, Kress B, Nennig E, Tronnier VM, Sartor K. Localizing and lateralizing language in patients with brain tumors: feasibility of routine preoperative functional MR imaging in 81 consecutive patients. Radiology. 2007;243:828-36.

Tharin S, Golby A.  Functional brain mapping and its applications to neurosurgery. Neurosurgery. 2007;60:185-201.

Chakraborty A, McEvoy AW.  Presurgical functional mapping with functional MRI. Current Opinion Neurology. 2008;24:446-51.

Bizzi A, Blasi V, Falini A, Ferroli P, Cadioli M, Danesi U, Aquino D, Marras C, Caldiroli D, Broggi G. Presurgical functional MR imaging of language and motor functions: validation with intraoperative electrocortical mapping. Radiology. 2008;248:579-89.

View Previous Versions

[Version 014 of M-13]
[Version 013 of M-13]
[Version 012 of M-13]
[Version 011 of M-13]
[Version 010 of M-13]
[Version 009 of M-13]
[Version 008 of M-13]
[Version 007 of M-13]
[Version 006 of M-13]
[Version 005 of M-13]
[Version 004 of M-13]
[Version 003 of M-13]
[Version 002 of M-13]
[Version 001 of M-13]

Table Attachment

Text Attachment

Procedure Code Attachment


Glossary





Medical policies do not constitute medical advice, nor are they intended to govern the practice of medicine. They are intended to reflect Highmark's reimbursement and coverage guidelines. Coverage for services may vary for individual members, based on the terms of the benefit contract.

Highmark retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Highmark. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.



back to top